Effect of Combined Intraosseous and Intraarticular Infiltrations of Autologous Platelet-Rich Plasma on Subchondral Bone Marrow Mesenchymal Stromal Cells from Patients with Hip Osteoarthritis.
ageing
hip OA
mesenchymal stromal cells (MSCs)
osteoarthritis (OA)
platelet rich plasma (PRP)
senescence
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
04 Jul 2022
04 Jul 2022
Historique:
received:
24
05
2022
revised:
30
06
2022
accepted:
01
07
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Osteoarthritis (OA) is a debilitating condition that significantly impacts its patients and is closely associated with advancing age and senescence. Treatment with autologous platelet rich plasma (PRP) is a novel approach that is increasingly being researched for its effects. Subchondral bone mesenchymal stromal cells (MSCs) are key progenitors that form bone and cartilage lineages that are affected in OA. This study investigated the changes in subchondral bone MSCs before and after combined intraosseous (IO) and intraarticular (IA) PRP infiltration. Patient bone marrow aspirates were collected from 12 patients (four male, eight female) aged 40-86 years old (median 59.5). MSCs were expanded in standard media containing human serum to passage 1 and analysed for their colony-forming potential, senescence status, and gene expression. Hip dysfunction and Osteoarthritis Outcome Score (HOOS) at baseline and 6 months post second infiltration were used to assess the clinical outcomes; seven patients were considered responders and five non-responders. The number of colony-forming MSCs did not increase in the post treatment group, however, they demonstrated significantly higher colony areas (14.5% higher compared to Pre) indicative of enhanced proliferative capacity, especially in older donors (28.2% higher). Senescence assays also suggest that older patients and responders had a higher resistance to senescent cell accumulation. Responder and non-responder MSCs tended to differ in the expression of genes associated with bone formation and cartilage turnover including osteoblast markers, matrix metalloproteinases, and their inhibitors. Taken together, our data show that in hip OA patients, combined IO and IA PRP infiltrations enhanced subchondral MSC proliferative and stress-resistance capacities, particularly in older patients. Future investigation of the potential anti-ageing effect of PRP infiltrations and the use of next-generation sequencing would contribute towards better understanding of the molecular mechanisms associated with OA in MSCs.
Identifiants
pubmed: 35807175
pii: jcm11133891
doi: 10.3390/jcm11133891
pmc: PMC9267269
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Basque Government
ID : ZL-2019/00227, ZL-2020/00278, ZL-2021/00775
Organisme : Provincial Council of Alava
ID : INNOEM-2019/00085, INNOEM-2020/00065
Références
Future Sci OA. 2017 Sep 06;3(4):FSO228
pubmed: 29134116
Bone. 2019 Apr;121:121-133
pubmed: 30659978
Arthritis Rheum. 2002 Mar;46(3):704-13
pubmed: 11920406
J Cell Mol Med. 2021 Jan;25(1):259-271
pubmed: 33305883
Nat Med. 2017 Jun;23(6):775-781
pubmed: 28436958
Sci Rep. 2021 Jan 13;11(1):1054
pubmed: 33441693
Am J Sports Med. 2017 Feb;45(2):339-346
pubmed: 28146403
Osteoarthritis Cartilage. 2020 Mar;28(3):324-333
pubmed: 31904489
Cell Transplant. 2017 Sep;26(9):1520-1529
pubmed: 29113463
Int J Mol Sci. 2021 Nov 12;22(22):
pubmed: 34830107
Genes (Basel). 2020 Jul 26;11(8):
pubmed: 32722615
Arthroscopy. 2012 Aug;28(8):1070-8
pubmed: 22840987
Stem Cells Int. 2017;2017:6129596
pubmed: 28298930
Sci Rep. 2019 Jun 27;9(1):9321
pubmed: 31249374
Front Bioeng Biotechnol. 2020 Oct 14;8:579751
pubmed: 33178674
Front Med (Lausanne). 2021 Nov 22;8:756029
pubmed: 34881261
Clin Rheumatol. 2018 May;37(5):1341-1350
pubmed: 29388085
Arthrosc Tech. 2017 Jun 19;6(3):e821-e825
pubmed: 28706837
Ther Adv Musculoskelet Dis. 2021 Mar 29;13:1759720X211004336
pubmed: 33854574
Nat Rev Rheumatol. 2016 Nov;12(11):632-644
pubmed: 27652499
Biomed Res Int. 2016;2016:4868613
pubmed: 27462609
Clin Orthop Relat Res. 2018 Aug;476(8):1680-1684
pubmed: 30020152
Nat Rev Rheumatol. 2021 Jan;17(1):47-57
pubmed: 33208917
Arthritis Rheumatol. 2016 Jul;68(7):1648-59
pubmed: 26866940
J Orthop Res. 2020 Sep;38(9):1931-1941
pubmed: 32129513
BMC Musculoskelet Disord. 2018 Jul 28;19(1):272
pubmed: 30055602
Osteoarthritis Cartilage. 2014 Aug;22(8):1077-89
pubmed: 24928319
PLoS One. 2018 May 24;13(5):e0197969
pubmed: 29795650
Int J Mol Sci. 2022 Mar 05;23(5):
pubmed: 35269990
Cartilage. 2019 Apr;10(2):245-253
pubmed: 29448817
Stem Cells Int. 2019 Aug 1;2019:5197983
pubmed: 31467563
Nat Med. 2013 Jun;19(6):704-12
pubmed: 23685840
Arthritis Rheum. 2012 Aug;64(8):2632-43
pubmed: 22378497
Cell Tissue Res. 2013 May;352(2):237-47
pubmed: 23397425
Rejuvenation Res. 2020 Oct;23(5):401-410
pubmed: 31847701
J Bone Miner Res. 2014 Jun;29(6):1311-21
pubmed: 24496911
Expert Opin Biol Ther. 2016;16(5):627-43
pubmed: 26930117
Sci Rep. 2019 Nov 22;9(1):17340
pubmed: 31758052
Am J Sports Med. 2022 Apr;50(5):1451-1461
pubmed: 34102078
Expert Opin Biol Ther. 2020 Dec;20(12):1447-1460
pubmed: 32692595
Health Qual Life Outcomes. 2003 Nov 03;1:64
pubmed: 14613558
Tissue Eng Part A. 2014 Jan;20(1-2):160-70
pubmed: 23924315
Biomedicines. 2020 Jul 15;8(7):
pubmed: 32679782
Sci Rep. 2021 Jun 1;11(1):11493
pubmed: 34075069
Knee Surg Sports Traumatol Arthrosc. 2017 Mar;25(3):958-965
pubmed: 26233594
Stem Cells Int. 2016;2016:1247950
pubmed: 27818688
Biomaterials. 2014 Dec;35(37):9767-9776
pubmed: 25239042